Top Markets
Coin of the day
Bloomage BioTechnology Corporation Limited Bloomage BioTechnology Corporation Limited

Bloomage BioTechnology Corporation Limited

688363
株式のランク #5709
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and... Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is based in Jinan, China.
株価
$5.21
時価総額
$2.49B
変化(1日)
-0.91%
変化(1年)
-34.46%
CN
取引 Bloomage BioTechnology Corporation Limited (688363)

カテゴリー

Bloomage BioTechnology Corporation Limited(688363)の収益
Aug 2026 時点の収益 TTM: 0
Bloomage BioTechnology Corporation Limited の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Bloomage BioTechnology Corporation Limited の収益履歴(2026 ~ 2026)
各年末の収益
収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差
$35.45B -
GB
- -
FR
$24.41B -
US
$16.84B -
US
$12.60B -
US